The frequency of KRAS mutations was 20.8 % in male patients and 33.2 % in female patients, 8.3 % in never smokers and 32.7 % in ever smokers, 29.9 % in adenocarcinoma tumors and 20.8 % in other NSCLC tumors [20]. Here, KRAS is linked to adenocarcinoma.